Objective: The Bristol Impact of Hypermobility (BIoH) questionnaire is a patient-reported outcome measure developed in conjunction with adults with Joint Hypermobility Syndrome (JHS). It has demonstrated strong concurrent validity with the Short Form-36 (SF-36) physical component score but other psychometric properties have yet to be established. This study aimed to determine its testretest reliability and smallest detectable change (SDC).Design: A test-retest reliability study.Setting: Participants were recruited from the Hypermobility Syndromes Association, a patient organisation in the United Kingdom.Patients: Recruitment packs were sent to 1,080 adults who had given permission to be contacted about research.
Main Outcome Measures:BIoH and SF-36 questionnaires were administered at baseline and repeated two weeks later. An 11-point global rating of change scale (-5 to +5) was also administered at two weeks. Test-retest analysis and calculation of the SDC was conducted on 'stable' patients (defined as global rating of change -1 to +1).
Conclusion:The results provide further evidence of the potential of the BIoH questionnaire to underpin research and clinical practice for people with JHS.